---
title: "Karyopharm治療 (KPTI.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/KPTI.US/norm.md"
symbol: "KPTI.US"
name: "Karyopharm治療"
parent: "https://longbridge.com/zh-HK/quote/KPTI.US.md"
datetime: "2026-05-21T21:57:45.336Z"
locales:
  - [en](https://longbridge.com/en/quote/KPTI.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KPTI.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KPTI.US/norm.md)
---

# Karyopharm治療 (KPTI.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -1.24 | -5.71 | -3.82 | -4.32 | -2.77 |
| ROE | 32.07% | 145.43% | 52.15% | 67.00% | 47.89% |
| 營業收入 | 35.07M | 34.08M | 44.04M | 37.93M | 30.02M |
| 凈利潤 | -22.39M | -102.20M | -33.13M | -37.25M | -23.46M |
| 營業利潤 | -26.76M | -17.84M | -15.22M | -24.39M | -33.26M |
| 毛利率 | 96.16% | 14.46% | 25.85% | 10.78% | -19.67% |
| 凈利率 | -63.86% | -299.89% | -75.21% | -98.22% | -78.17% |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 131.42M | 108.42M | 96.23M | 104.88M | 127.71M |
| 權益乘數 | -0.4947 | -0.3701 | -0.3574 | -0.4390 | -0.6203 |
| 每股凈資產 | -12.07 | -16.00 | -30.94 | -27.63 | -24.03 |
| 資產周轉率 | 1.17 | 1.07 | 0.9977 | 0.8610 | 0.8557 |
| 現金及短投 | 90.85M | 63.74M | 45.88M | 51.70M | 69.94M |
| 存貨與應收 | - | 4.04M | 3.97M | 4.99M | 4.77M |
| 長期投資 | - | 4.65M | 4.80M | 5.33M | 5.80M |
| 凈債務 | 205.88M | 242.20M | 224.04M | 212.42M | 190.26M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | - | -11.83M | -5.86M | -18.70M | -38.98M |
| 投資現金流 | - | 5.00M | 4.80M | 18.29M | 15.29M |
| 融資現金流 | - | 29.69M | 0.0000 | 356000.00 | - |
| 自由現金流 | - | -6.17M | 2.10M | -5.14M | -22.08M |
| 現金流充裕率 | - | -4731.20% | - | - | - |
| 舉債與償債 | - | 27.25M | - | - | - |
| 資本支出 | - | - | - | - | - |